Blog Posts
Eric Singhi, Young-Onset Lung Cancer
Eric Singhi/faculty.mdanderson.org

Eric K. Singhi: BAY88 Has a Name – Sevabertinib

Eric K. Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, shared a post on X:

“BAY88 has a name – Sevabertinib
Dr. Xiuning Le excellently reviews updates for the drug. Although small numbers, for treatment-naive patients, ORR ~60%.”

Eric K. Singhi: BAY88 Has a Name - Sevabertinib

More posts featuring Eric K. Singhi.

cancer Eric K. Singhi ICYMI OncoDaily Oncology Sevabertinib Xiuning Le